Hospitals in Morocco, Cameroon, and South Africa recently adopted its SOPHiA artificial intelligence offering, the firm's first crop of African customers.
The workgroup's goal is to encourage clinical labs to adopt uniform standards, so that clinical NGS test results can be compared among laboratories.
Investigators intend to genotype the biorepository using Illumina arrays with the aim of identifying markers that can be used to inform treatment and prevention efforts.
The company also announced that it is launching a new end-to-end clinical sequencing platform.
VISION aims to provide validated regulatory modules, quantitative models for gene regulation, and guides for translating research from mouse models to human.
Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.
OncoDNA has launched two new precision cancer medicine projects, the budgets for which total €16 million and are being supported in part by the Belgian Walloon Region.
The partners aim to identify master regulators in the molecular networks of GIST patients that can serve as drug targets for existing treatments.
The company also extended its existing licensing agreement with Genalice, signed in 2013, to improve plant DNA analysis.
Objectives for this year include building a network of ELIXIR beacons, developing new features and security measures, and partnering with data owners.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.